Cell Response to Novel Human Coronavirus Opens Possible Paths to Treatments

by Bidita Debnath on May 5, 2013 at 4:52 PM

WHAT:To study the cells' response to infection by a novel human coronavirus (called nCoV), NIH-supported scientists used lab-grown human lung cells.

And they compiled the information about which genes are significantly disrupted in xearly and late stages of infection. The information about host response to nCoV allowed the researchers to predict drugs that might be used to inhibit either the virus itself or the deleterious responses that host cells make in reaction to infection. Since nCoV was recognized in 2012, 17 confirmed cases and 11 deaths have been reported—a high fatality rate that is spurring urgent research efforts to better understand the virus and its effects.

Treatment for Coronavirus In Early Lab Tests Shows Promise

Scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

The investigators, led by Michael G. Katze, Ph.D., of the University of Washington, compared cellular gene expression responses to two viruses: the novel coronavirus and a coronavirus that caused a global outbreak of severe acute respiratory syndrome (SARS) in 2003. Although the viruses are in the same family, their effects on human cells are vastly different. In general, nCoV disrupted a greater number of human genes more profoundly and at more time points after infection than the SARS coronavirus. The team identified one set of 207 human genes whose expression differed from normal soon after infection with nCoV and remained disrupted throughout the course of infection. Notably, nCoV down-regulated the activity of a group of genes involved in signaling the presence of an invading virus to the immune system. Such down-regulation may cause a delay in the infection-fighting response.

The researchers used computational approaches to determine that certain classes of drugs, including specific kinase inhibitors and one type of glucocorticoid, act on some of the 207 human genes whose expression was found to be disrupted by nCoV. The team hypothesized that treatment with such drugs might block nCoV replication and disease progression in the host. In their current study, they tested this hypothesis using a kinase inhibitor on nCoV-infected cells grown in test tubes. They found that the drug did inhibit the ability of the virus to replicate. Additional studies are needed to see if kinase inhibitors could be useful alone or in combination with other drugs to treat nCoV infection in people.

To Study Novel Coronavirus Infection NIH Scientists Develop Monkey Model

A model of infection was developed in rhesus macaques by National Institutes of Health (NIH) researchers.

ARTICLE:L Josset et al. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio DOI: 10.1128/mBio.00165-13 (2013) http://mbio.asm.org/content/4/3/e00165-13.

WHO:Valentina Di Francesco, program officer, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, is available to discuss this research.

Source: Eurekalert

Font : A-A+

Novel Coronavirus Well-adapted to Humans, Susceptible to Immunotherapy: Study

According to a study the new coronavirus that has emerged in the Middle East is well-adapted to infecting humans but could potentially be treated with immunotherapy.

<< Endoscopic Treatment for Zenker's Diverticulum Offers Low C...

Government Launch Special Immunization Weeks to Widen Vacci... >>

New Strain of Coronavirus can Infect Humans and Bats Alike

A new study published in the journal mBio reveals that public health authorities are worried over a novel strain of human coronavirus that can infect both humans and bats.